You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 250 No. 8, August 26, 1983 TABLE OF CONTENTS
  JAMA
  •  Online Features
  COMMENTARY
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Insulin Pump Treatment of Diabetes

Decision-Making Without Definitive Data

Philip Felig, MD; Michael Bergman, MD

JAMA. 1983;250(8):1045-1047.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE ADVENT of treatment regimens involving the administration of insulin by portable pump1,2 has added a new dimension to the decision-making process regarding the ambulatory treatment of the insulin-dependent diabetic. Briefly, such regimens involve the continuous subcutaneous infusion of rapid-acting (regular) insulin in basal amounts plus patient-activated bolus doses of insulin delivered by the pump before meals.3 Adjustments in the basal or bolus doses of insulin are made on the basis of capillary blood glucose measurements performed by the patient on blood samples obtained by finger pricking several times per day.3 Although expensive ($1,100 to $2,500 per unit), the pumps are readily obtainable from a number of manufacturers in the United States,3 and their use in community-based clinical practice has rapidly increased within the past two years.4

The enthusiasm generated by reports of normal or near-normal blood glucose levels in pump-treated patients and the evidence . . . [Full Text PDF of this Article]


Author Affiliations

From the Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn (Dr Felig); and Department of Medicine, New York Medical College, Valhalla (Dr Bergman).


Footnotes

Reprint requests to Yale University School of Medicine, Department of Internal Medicine, Division of Endocrinology, 333 Cedar St, PO Box 3333, New Haven, CT 06510 (Dr Felig).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.